Noah Nasser, CEO of datma, on the Future of Molecular Lab Data Analysis

datma, a health tech company, has a vision of revolutionising the use of vast molecular laboratory data for research, innovation, and improving patient outcomes. In this exclusive interview, Noah Nasser, datma CEO, describes how datma.FED, datma’s federated real-world data platform, is linking molecular labs, health systems, and pharmaceutical companies.

Nasser explains how datma.FED enables labs to monetise their de-identified data in a safe manner, supporting the costs of reimbursed, non-reimbursed tests, and still comply with privacy regulations like HIPAA and GDPR. With high-quality, structured datasets, datma helps pharmaceutical firms derive actionable insights to create evidence, craft market access, and secure regulatory approval.

datma has a federated architecture, and data remains in the environment in the custodian, which allows sharing query-based insights to tackle challenges such as data fragmentation, privacy concerns, etc. The approach boosts collaboration along with the acceleration of precision medicine, and the results will eventually better results in healthcare. 

Looking ahead, Nasser talks about how datma is expanding globally, investing in AI-driven analytics, and launching new products like datma.WHY and datma.360 to push the boundaries of real-world evidence creation and personalised medicine. As the future of healthcare becomes increasingly data-driven, datma is leading the charge to unlock the true value of molecular lab data.

What is datma, and how did Noah Get Inspired for the Business?

Datma is a healthtech company committed to a federated real-world data platform that bridges data custodians (health systems and molecular labs) and data users (pharma companies). They aim at tapping into the untapped power of healthcare data by enabling health systems and labs to safely monetize their data and providing pharmaceutical companies with high-quality, appropriate datasets for creating evidence, market access, and sophisticated analytics.

The impetus for datma came about due to the recognition of enormous unleveraged value in healthcare information. Labs create critical intelligence through routine clinical services, but this data is not often leveraged to its full potential. At the same time, pharmaceutical firms struggle to deal with incomplete, fragmented, or inconsistent data sets that require significant time and resources to organize and analyze. 

How Does datma.FED Assist To Unlock and Use Data for Opportunities?

datma.FED allows the transformation of healthcare data into actionable insights without giving the data to custodians. With federated design, health systems and laboratories are able to develop new sources of revenue and help offset the costs of unreimbursed tests by making their de-identified datasets searchable in a secure, privacy-focused environment.

For pharma companies, datma.FED offers multimodal, high-resolution, research-ready datasets beyond typical claims or EHR information. This allows them to reply to some of the specific research questions along with optimising market access strategies. Datma develops a win-win situation for both data users as well as data custodians while advancing innovation in the healthcare sector. 

What’s Next for datma?

datma will revolutionise healthcare. We are expanding quickly through strategic partnerships with leading health systems, laboratories, and pharma innovators. This expansion, combined with our significant investment in generative AI analytics, will uncover potential to add trillions to the global economy.

Building on their strong foundation in US precision oncology, we are rapidly becoming an international leader. According to the CEO, datma will soon make its name as a company with secure, as well as high-quality data, which supports personalised medicine. Our datma.FED platform is the cornerstone of this vision, empowering researchers with large, multi-dimensional datasets.

Imagine a world where clinicians seamlessly work with Artificical Intelligence (AI), delivering the right, timely care while diminishing administrative work. That is the world datma is building. Their federated architecture ensures that data custodians are in control, enabling improvements in disease diagnosis and treatment.